Compounds > 5-fluorodopamine
Page last updated: 2024-09-03

5-fluorodopamine and Parkinson Disease, Secondary

5-fluorodopamine has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, J; Antoni, G; Aquilonius, SM; Haaparanta, M; Hartvig, P; Laihinen, A; Lundqvist, H; Rinne, U; Solin, O; Tedroff, J1

Other Studies

1 other study(ies) available for 5-fluorodopamine and Parkinson Disease, Secondary

ArticleYear
Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.
    Acta neurologica Scandinavica, 1990, Volume: 81, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Corpus Striatum; Dopamine; Female; Humans; Male; Middle Aged; Nomifensine; Parkinson Disease, Secondary; Tomography, Emission-Computed

1990